Recurrent Melanoma Completed Phase 1 Trials for Bryostatin 1 (DB11752)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00112476Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment